Dendropanoxide Attenuates High Glucose-induced Oxidative Damage in NRK-52E Cells via AKT/mTOR Signaling Pathway
Planta Medica · 01.04.2024 · 90 (04) · 256-266
DOI: 10.1055/a-2220-9301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.04.2024. Verfasst von Song Hee Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Seobu-ro 2066, Kyunggi-Do, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Hyperglycemia, Metformin, Triterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Hyperglycemia is a potent risk factor for the development and progression of diabetes-induced nephropathy. Dendropanoxide (DPx) is a natural compound isolated from Dendropanax morbifera (Araliaceae) that exerts various biological effects. However, the role of DPx in hyperglycemia-induced renal tubular cell injury remains unclear. The present study explored the protective mechanism of DPx on high glucose (HG)-induced cytotoxicity in kidney tubular epithelial NRK-52E cells. The cells were cultured with normal glucose (5.6 mM), HG (30 mM), HG + metformin (10 µM), or HG + DPx (10 µM) for 48 h, and cell cycle and apoptosis were analyzed. Malondialdehyde (MDA), advanced glycation end products (AGEs), and reactive oxygen species (ROS) were measured. Protein-based nephrotoxicity biomarkers were measured in both the culture media and cell lysates. MDA and AGEs were significantly increased in NRK-52E cells cultured with HG, and these levels were markedly reduced by pretreatment with DPx or metformin. DPx significantly reduced the levels of kidney injury molecule-1 (KIM-1), pyruvate kinase M2 (PKM2), selenium-binding protein 1 (SBP1), or neutrophil gelatinase-associated lipocalin (NGAL) in NRK-52E cells cultured under HG conditions. Furthermore, treatment with DPx significantly increased antioxidant enzyme activity. DPx protects against HG-induced renal tubular cell damage, which may be mediated by its ability to inhibit oxidative stress through the protein kinase B/mammalian target of the rapamycin (AKT/mTOR) signaling pathway. These findings suggest that DPx can be used as a new drug for the treatment of high glucose-induced diabetic nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Sungkyunkwan University, Seobu-ro 2066, Kyunggi-Do, Suwon, Republic of Korea.
- College of Pharmacy, Duksung Women's University, Seoul, Republic of Korea.
ORCID-Profile: Jeong Hwan Kwak
Zitieren
APA
Lee, S. H., Kim, J. R., Shin, J. K., Lee, J. S., Kim, Y. M., Kwak, J. H., & Kim, H. S. (2024). Dendropanoxide Attenuates High Glucose-induced Oxidative Damage in NRK-52E Cells via AKT/mTOR Signaling Pathway. Planta Medica, 90(04), 256-266. https://doi.org/10.1055/a-2220-9301
Vancouver
Lee SH, Kim JR, Shin JK, Lee JS, Kim YM, Kwak JH, et al. Dendropanoxide Attenuates High Glucose-induced Oxidative Damage in NRK-52E Cells via AKT/mTOR Signaling Pathway. Planta Medica. 2024;90(04):256-266. doi:10.1055/a-2220-9301
BibTeX
@article{Lee2024,
author = {Lee, Song Hee and Kim, Ju Ri and Shin, Joo Kyung and Lee, Jin-Sol and Kim, Young Mi and Kwak, Jeong Hwan and Kim, Hyung Sik},
title = {Dendropanoxide Attenuates High Glucose-induced Oxidative Damage in NRK-52E Cells via AKT/mTOR Signaling Pathway},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {04},
pages = {256--266},
doi = {10.1055/a-2220-9301}
}
EUVIMED